Being pro-oncogenic, the overexpression of AGR2 enhanced clonogenic growth and cancer cells survival, rather than inhibiting the growth of the cells in the premalignant Barrett's oesophagus and oesophageal cancers [17]. This evidence concerns the gene AGR2 and carcinoma of esophagus.